Generated by GPT-5-mini| Altman DG | |
|---|---|
| Name | Douglas G. Altman |
| Birth date | 14 November 1948 |
| Death date | 3 June 2018 |
| Nationality | British |
| Occupation | Statistician, author, academic |
| Alma mater | University of Oxford, University of Bristol |
| Known for | Medical statistics, research reporting, meta-analysis, CONSORT |
Altman DG was a British statistician and influential methodological reformer whose work transformed the reporting and interpretation of medical research. He combined expertise in statistical methodology with energetic advocacy for transparent reporting, reproducible research, and better peer review across biomedical journals. Altman built strong collaborations with clinicians, editors, and researchers at institutions and organizations internationally to improve trial reporting, diagnostic research, and observational study methods.
Altman was born in the United Kingdom and educated at University of Oxford and University of Bristol, where he trained in mathematics and statistics and developed interests that bridged quantitative methods and clinical research. During his formative years he was influenced by statisticians and epidemiologists active in British health research settings, and he later held appointments that connected him with research at Royal College of Physicians, Medical Research Council, and clinical departments in teaching hospitals. His early exposure to clinical practice and biomedical journals shaped his lifelong focus on the clarity and reliability of published research.
Altman held academic posts including professorship at University of Oxford and collaboration with departments at University of Bristol and institutions such as University College London. He contributed foundational work in areas including meta-analysis, diagnostic test evaluation, measurement error, method comparison studies, and the design and analysis of randomized controlled trials associated with organizations like the Medical Research Council and the Wellcome Trust. Altman was a prominent advocate within editorial and scholarly communities including the BMJ and the Lancet, promoting rigorous statistical practice in clinical trials reported by journals such as New England Journal of Medicine and JAMA.
He co-founded and directed initiatives addressing research waste and reproducibility alongside figures affiliated with entities such as the Cochrane Collaboration, the National Institute for Health and Care Excellence, and the World Health Organization. Through methodological papers and commentaries, Altman challenged common statistical misuses seen across reports in specialties represented by associations like the Royal College of Surgeons and the American College of Physicians. His collaborations extended to methodologists at Harvard University, Johns Hopkins University, University of Toronto, University of Cambridge, and other centers of biomedical research.
Altman emphasized transparent reporting, appropriate use of confidence intervals, avoidance of dichotomous p-value overinterpretation, and careful handling of prognostic models used in oncology, cardiology, and public health contexts linked to organizations such as European Society for Medical Oncology and American Heart Association. He supported educational efforts with professional societies including the Royal Statistical Society and the International Statistical Institute to improve statistical literacy among clinicians and editors.
Altman authored and co-authored influential texts and guidelines widely used within clinical research. He was co-author of a standard textbook in medical statistics published with colleagues from institutions like University College London and University of Cambridge, and he produced practical guidance for the interpretation of diagnostic studies used by practitioners affiliated with Royal College of Pathologists.
He was a driving force behind reporting initiatives including the CONSORT statement for randomized trials, developed with collaborators from University of Oxford, the Cochrane Collaboration, the CONSORT Group, and journal editors from BMJ and Lancet. Altman also contributed to reporting standards for observational studies (often referenced alongside the STROBE statement promoters at institutions such as University of London), diagnostic accuracy studies (linked to developers associated with Cochrane Diagnostic Test Accuracy Group), and prognostic model research where guidance was endorsed by guideline groups connected to National Institutes of Health and professional bodies like the British Medical Association.
His methodological papers appeared in leading journals including BMJ, Lancet, Statistics in Medicine, and Journal of Clinical Epidemiology. These works provided practical tools for clinicians working in specialties represented by journals such as Gut, Thorax, Annals of Internal Medicine, and Cancer Research.
Altman received recognition from academic and professional bodies including fellowships with the Royal Statistical Society and honours from university departments at University of Bristol and University of Oxford. He was awarded prizes and lifetime achievement recognitions by editorial groups and learned societies involved with clinical epidemiology and biostatistics, including organizations like the Cochrane Collaboration and the International Society for Clinical Biostatistics. Journals and institutions such as BMJ and the Wellcome Trust acknowledged his impact on research reporting and reproducibility.
Colleagues remember Altman for mentorship to generations of statisticians and clinicians at institutions including University of Oxford, University of Bristol, Imperial College London, and international collaborators in the United States and Europe. His legacy endures through the CONSORT and related reporting guidelines, widely adopted by journals including BMJ, Lancet, and New England Journal of Medicine, and through training programs run by organizations such as the Cochrane Collaboration and the Royal College of Physicians. Altman’s emphasis on transparency, reproducibility, and methodological clarity continues to influence editorial policy, clinical research practice, and statistical education worldwide.
Category:British statisticians Category:Medical statisticians Category:1948 births Category:2018 deaths